News & Updates

In the treatment of patients with early oligoarticular psoriatic arthritis (PsA), the use of apremilast yields substantial improvements in both clinical and patient-reported outcomes, as shown in the results of the phase IV FOREMOST study.

Children with juvenile idiopathic arthritis (JIA) show similar well-being and academic performance as those without JIA, according to a study.

Tofacitinib demonstrates greater efficacy than placebo at week 12 in patients with ankylosing spondylitis (AS) regardless of their baseline C-reactive protein (CRP) levels, a study has shown.

Telehealth appropriateness is significantly associated with provider preference, the current and previous encounter modality, and rheumatoid arthritis (RA) disease activity, but not with RA medications, patient demographics, and comorbid noninflammatory causes of joint pain, a study has shown.

Circulating interleukin (IL)-17A in patients diagnosed with rheumatoid arthritis (RA) is associated with the incidence of cardiovascular disease (CVD), independent of traditional CVD risk factors and of erythrocyte sedimentation rate (ESR) at the time of diagnosis, suggests a study.

A triage led by a physiotherapist (PT) performs as reliably as a rheumatologist triage of referrals for joint pain, with significantly fewer patients with inflammatory arthritis (IA) needing an in-clinic visit, a recent study has shown.

An economic evaluation study by the University of Hong Kong (HKU) found treatment with biosimilar disease-modifying antirheumatic drugs (DMARDs) to be cost-effective compared with leflunomide in patients with rheumatoid arthritis (RA) who failed initial treatment with methotrexate (MTX).